囊性纤维化患者管理和真菌流行病学组织。
Organization of Patient Management and Fungal Epidemiology in Cystic Fibrosis.
机构信息
Department of Pediatric Pneumology and Immunology, Cystic Fibrosis Center Berlin/Charité-Universitätsmedizin Berlin, Berlin, Germany.
Laboratory of Parasitology-Mycology, Angers University hospital, Angers, France.
出版信息
Mycopathologia. 2018 Feb;183(1):7-19. doi: 10.1007/s11046-017-0205-x. Epub 2017 Nov 3.
Abstract
The achievement of a better life for cystic fibrosis (CF) patients is mainly caused by a better management and infection control over the last three decades. Herein, we want to summarize the cornerstones for an effective management of CF patients and to give an overview of the knowledge about the fungal epidemiology in this clinical context in Europe. Data from a retrospective analysis encompassing 66,616 samples from 3235 CF patients followed-up in 9 CF centers from different European countries are shown.
摘要
囊性纤维化（CF）患者生活质量的提高主要归因于过去三十年中对其疾病的更好管理和感染控制。在此，我们想要总结 CF 患者有效管理的基石，并概述欧洲这一临床背景下真菌流行病学的相关知识。本文的数据来源于一项回顾性分析，涵盖了来自 9 个欧洲国家不同 CF 中心的 3235 名 CF 患者的 66616 个样本。
相似文献
1
Organization of Patient Management and Fungal Epidemiology in Cystic Fibrosis.
Mycopathologia. 2018 Feb;183(1):7-19. doi: 10.1007/s11046-017-0205-x. Epub 2017 Nov 3.
2
Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center.
Med Mycol. 2016 Nov 1;54(8):781-6. doi: 10.1093/mmy/myw035. Epub 2016 Jun 30.
3
Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis.
J Cyst Fibros. 2014 Dec;13(6):667-73. doi: 10.1016/j.jcf.2014.01.011. Epub 2014 Feb 12.
4
Progress and challenges in fungal lung disease in cystic fibrosis.
Curr Opin Pulm Med. 2022 Nov 1;28(6):584-590. doi: 10.1097/MCP.0000000000000921. Epub 2022 Sep 19.
5
Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.
World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.
6
Fungal epidemiology in cystic fibrosis patients with a special focus on Scedosporium species complex.
Microb Pathog. 2019 Apr;129:168-175. doi: 10.1016/j.micpath.2019.02.009. Epub 2019 Feb 8.
7
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
J Cyst Fibros. 2021 Jul;20(4):566-577. doi: 10.1016/j.jcf.2021.03.017. Epub 2021 Apr 18.
8
Invasive Pulmonary Fungal Infections in Cystic Fibrosis.
Mycopathologia. 2018 Feb;183(1):33-43. doi: 10.1007/s11046-017-0199-4. Epub 2017 Sep 1.
9
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.
Mycopathologia. 2018 Feb;183(1):21-32. doi: 10.1007/s11046-017-0182-0. Epub 2017 Jul 31.
10
Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors.
PLoS One. 2017 Feb 8;12(2):e0171485. doi: 10.1371/journal.pone.0171485. eCollection 2017.
引用本文的文献
1
First environmental survey of species in Lebanon.
Front Cell Infect Microbiol. 2025 Mar 3;15:1547800. doi: 10.3389/fcimb.2025.1547800. eCollection 2025.
2
Metagenomics Applied to the Respiratory Mycobiome in Cystic Fibrosis.
Mycopathologia. 2024 Sep 12;189(5):82. doi: 10.1007/s11046-024-00887-6.
3
Exophiala species in household environments and their antifungal resistance profile.
Sci Rep. 2024 Jul 31;14(1):17622. doi: 10.1038/s41598-024-68166-4.
4
Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254090. doi: 10.1177/17534666241254090.
5
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections.
Clin Microbiol Rev. 2024 Jun 13;37(2):e0000423. doi: 10.1128/cmr.00004-23. Epub 2024 Mar 29.
6
Dot Immunobinding Assay for the Rapid Serodetection of / in Cystic Fibrosis Patients.
J Fungi (Basel). 2023 Jan 24;9(2):158. doi: 10.3390/jof9020158.
7
The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives.
Microorganisms. 2022 Apr 13;10(4):810. doi: 10.3390/microorganisms10040810.
8
-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Eur Respir Rev. 2021 Nov 17;30(162). doi: 10.1183/16000617.0103-2021. Print 2021 Dec 31.
9
Emerging Fungal Threats in Cystic Fibrosis.
Mycopathologia. 2021 Oct;186(5):639-653. doi: 10.1007/s11046-021-00574-w. Epub 2021 Jul 28.
10
Managing Fungal Infections in Cystic Fibrosis Patients: Challenges in Clinical Practice.
Infect Drug Resist. 2021 Mar 22;14:1141-1153. doi: 10.2147/IDR.S267219. eCollection 2021.
本文引用的文献
1
Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center.
Med Mycol. 2016 Nov 1;54(8):781-6. doi: 10.1093/mmy/myw035. Epub 2016 Jun 30.
2
Chronic lung infection caused by Trichosporon mycotoxinivorans and tricosporin mucoides in an immunocompetent cystic fibrosis patient.
Arch Bronconeumol. 2016 Jul;52(7):400. doi: 10.1016/j.arbres.2015.11.013. Epub 2015 Dec 30.
3
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety.
Thorax. 2016 Jan;71(1):26-34. doi: 10.1136/thoraxjnl-2015-207488. Epub 2015 Oct 9.
4
Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis.
Clin Exp Allergy. 2015 Dec;45(12):1765-78. doi: 10.1111/cea.12595.
5
Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parameters.
Invest Radiol. 2015 Oct;50(10):733-42. doi: 10.1097/RLI.0000000000000178.
6
First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature.
Mycoses. 2015 Aug;58(8):506-10. doi: 10.1111/myc.12340. Epub 2015 Jun 9.
7
Future trends in cystic fibrosis demography in 34 European countries.
Eur Respir J. 2015 Jul;46(1):133-41. doi: 10.1183/09031936.00196314. Epub 2015 Mar 18.
8
Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.
J Cyst Fibros. 2015 Mar;14(2):237-41. doi: 10.1016/j.jcf.2014.12.014. Epub 2015 Jan 13.
9
Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
Clin Infect Dis. 2015 Mar 1;60(5):703-12. doi: 10.1093/cid/ciu944. Epub 2014 Nov 25.
10
Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries.
Thorax. 2014 Dec;69(12):1090-7. doi: 10.1136/thoraxjnl-2014-205983. Epub 2014 Sep 21.
Zotero 插件